These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3037167)

  • 1. Effects on angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis.
    Levenson DJ; Dzau VJ
    Kidney Int Suppl; 1987 May; 20():S173-9. PubMed ID: 3037167
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks of angiotensin converting enzyme inhibition in renal artery stenosis.
    Wenting GJ; Derkx FH; Tan-Tjiong LH; van Seyen AJ; Man in't Veld AJ; Schalekamp MA
    Kidney Int Suppl; 1987 May; 20():S180-3. PubMed ID: 3037168
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrarenal effects of angiotensin II in renal artery stenosis.
    Anderson WP; Woods RL
    Kidney Int Suppl; 1987 May; 20():S157-67. PubMed ID: 3298798
    [No Abstract]   [Full Text] [Related]  

  • 5. Total and split renal function in patients with renovascular hypertension: effects of angiotensin-converting enzyme inhibition.
    Reams GP; Singh A; Logan KW; Holmes RA; Bauer JH
    J Clin Hypertens; 1987 Jun; 3(2):153-63. PubMed ID: 3039075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.
    Hollenberg NK; Swartz SL; Passan DR; Williams GH
    N Engl J Med; 1979 Jul; 301(1):9-12. PubMed ID: 221809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
    Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
    J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of inhibition of converting enzyme by perindopril on renal hemodynamics and natriuresis in essential arterial hypertension].
    Chaignon M; Barrou Z; Ayad M; Guédon J
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():151-4. PubMed ID: 3142399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal function after administration of angiotensin-converting enzyme inhibitors].
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Schweiz Med Wochenschr; 1987 Sep; 117(37):1359-62. PubMed ID: 3672075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deterioration of renal function after converting enzyme inhibition in a patient with renal artery stenosis after transplantation.
    Van Son WJ; Donker AJ; Van der Woude FJ; Meijer S; Slooff MJ; Tegzess AM; Van der Slikke LB
    Neth J Med; 1984; 27(1):10-3. PubMed ID: 6324009
    [No Abstract]   [Full Text] [Related]  

  • 12. Ischemic nephropathy/azotemic renovascular disease.
    Textor SC; Wilcox CS
    Semin Nephrol; 2000 Sep; 20(5):489-502. PubMed ID: 11022902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effect of captopril on single kidney glomerular filtration rate in arterial hypertension.
    Fommei E; Ghione S; Palla L; Rosa C; Mosca F; Ferrari M; Palombo C; Donato L
    J Hypertens Suppl; 1985 Nov; 3(2):S137-8. PubMed ID: 3910769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of renal function in hypertension due to unilateral renal artery occlusion.
    Tsuji Y; Goldfarb DA; Masaki Z; Ferrario CM
    Clin Exp Hypertens A; 1992; 14(6):1067-81. PubMed ID: 1358485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modification of renal hemodynamics and proteinuria in patients with arterial hypertension and kidney diseases].
    Risler T; Erley CM
    Z Kardiol; 1993; 82 Suppl 4():39-44. PubMed ID: 7908476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal functional changes after converting enzyme inhibition or nitroprusside in hypertensive rats.
    Lee HB; Blaufox MD
    Contrib Nephrol; 1987; 56():87-94. PubMed ID: 3038467
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
    Plante GE; Chainey A; Sirois P; Devissaguet M
    J Hypertens Suppl; 1988 Dec; 6(3):S69-73. PubMed ID: 3066878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interdependence of food intake and angiotensin converting enzyme inhibition on kidney function.
    Corman B; Michel JB
    J Hypertens Suppl; 1988 Dec; 6(3):S65-8. PubMed ID: 3225691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
    Burnier M; Waeber B; Nussberger J; Brunner HR
    J Hypertens Suppl; 1989 Sep; 7(7):S27-31. PubMed ID: 2693654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.